I S Fraser

No ORCID on file · 59 papers in corpus
nonrandomized-trial 1996
Obstetrics & Gynecology ·doi:10.1016/0029-7844(96)00085-3

OBJECTIVE: To assess the medium-term efficacy of rollerball endometrial ablation. METHODS: From January 1990 to December 1993, 142 women underwent rollerball endometrial ablation for menorrhagia, most with ovulatory dysfunctional uterine b…

other 1996
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a019534

Irregular menstrual bleeding in users of hormonal contraception represents the single major reason for discontinuation of these contraceptive methods. The mechanisms which underlie these bleeding disturbances are poorly understood, but appe…

other 1995
The Medical journal of Australia ·doi:10.5694/j.1326-5377.1995.tb138432.x
observational 1994
The Medical journal of Australia ·doi:10.5694/j.1326-5377.1994.tb138344.x

OBJECTIVE: To review the characteristics and experience of Australian women treated with depot medroxyprogesterone acetate (DMPA) in one gynaecological practice in Melbourne since 1973. DESIGN: A detailed retrospective review of clinical d…

review 1994
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1994.tb13688.x

Menorrhagia is a symptom denoting excessively heavy menstrual bleeding. It is a complaint that is difficult to verify objectively in many cases, even with a detailed case history. Issues of perception and tolerance of symptoms are important…

other 1993
British journal of hospital medicine
review 1992
Bailliere's clinical obstetrics and gynaecology ·doi:10.1016/s0950-3552(05)80191-9
review 1992
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1992.tb13538.x
rct 1991
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/j.1479-828x.1991.tb01807.x

A randomized and double-blind trial was carried out comparing intranasal nafarelin acetate (400 micrograms daily) and oral danazol (600 mg daily), given over 6 months, in the treatment of 49 patients with laparoscopically proven endometrios…

rct 1991
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/j.1479-828x.1991.tb02769.x

A series of 45 ovulatory women with a complaint of menorrhagia were randomized into 3 treatment groups, before receiving therapy with mefenamic acid in 2 cycles and 1 of 3 other agents in 2 cycles: naproxen (group 1; n = 14), a low dose mon…

observational 1990
American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(90)90032-3

Menstrual blood loss was measured in 139 of 182 women who had hysteroscopy after a complaint of menorrhagia, and a preliminary diagnosis of dysfunctional uterine bleeding. Laparoscopy was also performed in 117 of these women; only 51% did n…

other 1989
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/j.1479-828x.1989.tb01779.x

Forty-two women with laparoscopically-confirmed pelvic endometriosis (assessed according to the American Fertility Society modified classification) had serum levels of the cell-surface antigen CA-125 measured before, during and after medica…

case-report 1989
Obstetrics and gynecology

Successful pregnancy in a patient with isolated congenital partial cervical atresia is reported for the second time. She presented with primary amenorrhea, abdominopelvic pain, and endometriosis. After a late diagnosis, successful repair of…

review 1989
Bailliere's clinical obstetrics and gynaecology ·doi:10.1016/s0950-3552(89)80029-x
observational 1987
American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(87)90229-8

Endometrial blood flow was measured through the menstrual cycle in nonpregnant women (28 studies of 17 women with normal menstrual cycles and 32 studies of 20 women with dysfunctional uterine bleeding) with use of a clearance technique in w…

observational 1986
Obstetrics and gynecology

Fifty-five women with a convincing clinical history of menorrhagia associated with recognizable pelvic disease (40 women) or a confirmed coagulation disorder (15 women) were studied through one or more cycles with measurements of menstrual …

case-report 1985
Clinical reproduction and fertility ·doi:10.1097/00006254-198501000-00015

Four women out of 242 experienced amenorrhoea in excess of 6 months duration following danazol treatment. Two of these exhibited an unusual monotropic rise of FSH into the post menopausal range for 4-5 months following the end of therapy. T…

nonrandomized-trial 1985
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/j.1479-828x.1985.tb00649.x

Twenty-six women completed a 6-month course of treatment with danazol (at various dosages between 200 and 800 mg daily) for menorrhagia due to dysfunctional uterine bleeding. Objective measurements of menstrual blood loss (MBL) were underta…

other 1983
Clinical chemistry

Investigating the interference of danazol in testosterone radioimmunoassays, we measured serum testosterone concentrations in the serum of women receiving danazol, with three testosterone radioimmunoassay kits. All of these showed positive …

1983
·doi:10.1093/clinchem/29.1.141

Abstract Investigating the interference of danazol in testosterone radioimmunoassays, we measured serum testosterone concentrations in the serum of women receiving danazol, with three testosterone radioimmunoassay kits. All of these showed …

nonrandomized-trial 1982
Fertility and sterility ·doi:10.1016/s0015-0282(16)46152-2

Gonadotropin-releasing hormone (GnRH) tests (12 women) and estradiol benzoate stimulation tests (8 women) were carried out before and during short- or long-term treatment with danazol. There was no difference in the height or timing of lute…

nonrandomized-trial 1982
Fertility and sterility ·doi:10.1016/s0015-0282(16)46153-4

Eight subjects with normal menstrual cycles were treated with danazol (800 mg daily) during one luteal phase to assess the effect on follicular development in the subsequent cycle. Plasma levels of luteinizing hormone (LH), follicle-stimula…

other 1981
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem-53-1-149

The synthetic steroid, danazol [17 alpha-pregna-2,4-dien-20-yno-(2,3,d)isoxazol-17-ol], is used widely for the treatment of endometriosis. In nine subjects studied over a 6-month course of treatment and for 5 months subsequently, plasma hig…

rct 1981
Obstetrics & Gynecology

Sixty-nine patients with a convincing history of menorrhagia completed a 4-cycle double-blind randomized placebo-controlled crossover trial of mefenamic acid taken during menstruation. Only 30 of these patients demonstrated objective menorr…

other 1981
Clinical chemistry ·doi:10.1093/clinchem/27.4.603

We describe a problem in measuring serum testosterone concentrations in the serum of women who are taking danazol. The Diagnostic Products Corporation testosterone radioimmunoassay gives very high apparent testosterone concentrations in the…